Anti-MUC18 monoclonal antibody

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-MUC18 monoclonal antibody
Drug Alias NameABX-MA1Monoclonal antibody ABX-MA1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionMelanoma cell adhesion molecule inhibitors
TargetsMelanoma cell adhesion molecule
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbgenix Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbgenix Incorporated
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A